PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of ccLink to Publisher's site
 
Cell Cycle. Sep 15, 2010; 9(18): 3674–3679.
Published online Sep 15, 2010. doi:  10.4161/cc.9.18.13121
PMCID: PMC3047796

Damage-specific modification of PCNA

Abstract

Okazaki fragment processing is an integral part of DNA replication. For a long time, we assumed that the maturation of these small RNA-primed DNA fragments did not necessarily have to occur during S phase, but could be postponed to late in S phase after the bulk of DNA synthesis had been completed. This view was primarily based on the arrest phenotype of temperature-sensitive DNA ligase I mutants in yeast, which accumulated with an almost fully duplicated set of chromosomes. However, many temperature-sensitive alleles can be leaky and the re-evaluation of DNA ligase I-deficient cells has offered new and unexpected insights into how cells keep track of lagging strand synthesis. It turns out that if Okazaki fragment joining goes awry, cells have their own alarm system in the form of ubiquitin that is conjugated to the replication clamp PCNA. Although this modification results in mono- and poly-ubiquitination of PCNA, it is genetically distinct from the known post-replicative repair mark at lysine 164. In this Extra View, we discuss the possibility that eukaryotic cells utilize different enzymatic pathways and ubiquitin attachment sites on PCNA to alert the replication machinery to the accumulation of single-stranded gaps or nicks behind the fork.

Key words: DNA ligase I, DNA replication, Okazaki fragment processing, PCNA, ubiquitin, SUMO

Introduction

In humans, more than 30,000,000 Okazaki fragments (OFs) have to be initiated (assuming an average size of ~200 nt/OF), processed and ligated during a single round of DNA replication.1 It is easy to imagine that failure to properly join OFs would cause a large number of single-strand breaks (SSBs)—at a frequency that would likely overwhelm the SSB repair machinery and thus be lethal. It is therefore not surprising that to date only one individual with a severe defect in DNA ligase I, the enzyme that joins OFs during DNA replication, has been identified and described.2,3 The individual carried compound heterozygous mutations in the gene and retained approximately 5% ligase activity.4,5 Importantly, this reduction caused growth retardation, immunodeficiency, UV sensitivity and lymphoma.2,3 Most of these phenotypes are compatible with the known function of DNA ligase I in DNA replication and nucleotide excision repair.6 The only exception is the immunodeficiency, which went hand-in-hand with a profound lack of immunoglobulin class switching.2,3 Although this latter defect was not recapitulated in a mouse model carrying a homozygous mutation of the viable missense allele, DNA ligase I-deficient animals displayed growth retardation, abnormal erythropoiesis and increased genome instability.7,8 Moreover, they developed an unexpectedly wide range of spontaneous tumors, such as lymphomas, adeno- and other carcinomas. The importance of proper OF maturation is further underscored by the fact that mutations in other enzymes that participate in OF processing, such as the flap endonuclease Fen1 (e.g., a E160D mutation), which retains partial endonuclease activity,9 have been directly linked to cancer in humans.10 Interestingly, recent evidence suggests that the E160D Fen1 mutation, similar to the DNA ligase I deficiency, causes early-onset lymphoma in mice.11 This raises the question of whether cells harbor a system capable of monitoring perturbations during OF processing. In addition, it remains unclear if abnormalities in lagging strand maturation affect replication fork progression. This is exactly what we set out to explore in a recent study that was published earlier this year.12

Post-Replicative Repair and DNA Damage Induction by Okazaki Fragment Processing Defects

Today we have a relatively good understanding of the post-replication repair (PRR) pathways involved in sensing DNA lesions, like ultraviolet (UV) irradiation-induced thymine dimers,13 in the leading or lagging strand template.1416 PRR seemed for many years somewhat of a misnomer, as most studies analyzed the pathway in the context of an active replication fork.1721 However, recent studies have come full circle demonstrating that PRR can occur outside of S phase, after replication has been largely completed.22,23 The first description of PRR dates back to 1968 when Rupp and Howard-Flanders described discontinuities in the newly synthesized DNA of nucleotide excision repair (NER) defective E. coli.24 Shortly thereafter, the concept was extended to mammalian cells.25 During the past 42 years much progress has been made toward understanding error-prone and error-free PRR, respectively.26 Nevertheless, most studies published to date utilize UV or other mutagens like methyl methanesulfonate (MMS) to create large adducts in the DNA that prompt collisions with the replicative polymerases, thereby causing transient replication fork arrest.21,2729 This is usually accompanied by formation of long stretches of replication protein A (RPA)-coated, single-stranded (ss) DNA.30 These RPA-coated regions facilitate PRR activation by ubiquitination of PCNA at lysine 164,18,31 and also trigger the S phase checkpoint.30 Both events are genetically separable and are thought to occur in parallel.20,32 Although the abovementioned experimental approach utilizing UV-irradiation or MMS has provided a powerful model to dissect the molecular steps of these pathways, it has obvious limitations, because forks that accumulate ssDNA are probably not the only structures that arise in replication-defective mutants. Aberrant Okazaki fragment processing, for example, can cause nicks—in a wide range of varieties: “clean” nicks due to ligation deficiency, “dirty” nicks that exhibit adenylated 5′ ends if the ligation reaction is aborted prematurely or “flapped” nicks in the case of improper removal of RNA primers.33,34 This latter reaction requires the complicated interplay of multiple activities. Limited displacement synthesis by DNA polymerase (pol)-δ is required to initially create a short flap that is deleted one nucleotide at a time by Fen1.35 Excessive strand displacement is counteracted by the intrinsic 3′-exonuclease activity of the catalytic subunit of pol-δ and its non-essential binding partner, Pol32.36,37 Cells defective in Fen1, appear to create larger flaps (in a Pol32-dependent manner) that can be processed by a second endonuclease, Dna2.3840 Recent studies have also implicated other enzymes, such as exonuclease 1 and the helicase Pif1 in this backup system.37,41 Thus, the first two steps (strand displacement and flap removal) of OF processing (OFP) already involve an elaborate network of partially redundant pathways to assure proper production of a ligatable nick that can be sealed by DNA ligase I. Importantly, primer removal by Fen1 and OF ligation by DNA ligase I are coordinated by PCNA.42 Both enzymes bind PCNA through a PCNA interacting peptide (PIP) box.4345

Okazaki Fragment Processing Defects Trigger PCNA Ubiquitination

The fact that multiple OFP pathways exist suggests that cells have the ability to actively monitor maturation events during lagging strand synthesis. To address this question, we analyzed DNA ligase I-deficient cells.46 In budding yeast, temperature-sensitive cdc9 mutants were among the first strains identified to have a cell cycle progression defect under non-permissive conditions as they arrested in late S/G2 phase.4749 The arrest was dependent on the DNA damage response50 and cell viability required functional homologous recombination,51 indicating that the nicks might be—at least partially—converted into double strand breaks (DSBs). These early studies suggested that OF ligation was uncoupled from replication fork progression and could occur very late in S phase after the bulk of the DNA had been replicated. This was also consistent with observations made much later that PCNA remained on chromatin after passage of the replication fork, providing anchor points for DNA ligase I on chromatin.52 In fact, experiments with cdc9-1 cells that had two consecutive shifts, to the non-permissive temperature first and then back to the permissive temperature demonstrated that OF synthesis could be temporally separated from OF ligation.46 All of these findings were consistent with the notion that DNA ligase I was not required until the end of S phase. However, our recent analysis of the cdc9-1 mutation in a different strain background suggested that the cells do not move through S phase with normal kinetics, but rather appeared to accumulate in mid-S phase.12 Further exploration of a temperature-sensitive degron mutant (cdc9-td) verified that DNA replication was extensively delayed in the absence of DNA ligase I (Fig. 1). Although it still remains unclear how this delay was mediated (e.g., through reduced fork progression or inhibition of late-firing origins), it was dependent on the activation of the S phase checkpoint kinase Rad53.53 Rad53 phosphorylation was not only Rad9- (and thus DNA damage) dependent,54 but also required the mediator of the replication checkpoint, Mrc1,55,56 the yeast homolog of Claspin.57 This finding implied that replication fork stalling was occuring.58,59 How this happened in a scenario in which none of the DNA polymerases were actively inhibited was puzzling. Even more surprising was the observation that the phosphorylation of Rad53 was amplified by a novel PRR-related pathway that triggered mono- and poly-ubiquitination of PCNA.12 Mutation of lysine 164 of PCNA in cdc9 mutants had no effect on cell viability, arguing that neither error-prone translesion synthesis19,21,6062 nor error-free replication by template switch6366 played a role in this process. Instead, we observed synthetic lethality between cdc9-1 and a mutation in lysine 107 of PCNA, leading us to propose that ubiquitin is conjugated to lysine 107 in DNA ligase I-deficient cells. One aspect that we did not address in our recent study is whether PCNA is also modified by the ubiquitin-related SUMO peptide, which is attached to PCNA during S phase at lysine 164 and to a lesser extent at lysine 127.18 In Figure 2, we demonstrate that PCNA is indeed sumoylated in wild-type cells and cdc9 mutants. Because the mutants accumulated in S phase, they displayed stronger sumoylation signals. In addition, we observed higher molecular weight forms of sumoylated PCNA. This is consistent with the finding that PCNA carries SUMO chains in the face of profound replication stress.67 Alternatively, it is also possible that a single PCNA monomer is ubiquitinated (at lysine 107) and sumoylated (at lysine 164) in cdc9 mutants. Sumoylation of PCNA is thought to repress homologous recombination6870 at stalled replication forks. This raises an interesting point because homologous recombination is required for the viability of cdc9 mutants and therefore its activity needs to be highly regulated. Future experiments are needed to clarify these issues. However, regardless of their outcome, it is important to mention that ubiquitination of PCNA is conserved in human cells that are depleted for DNA ligase I, even though lysine 107 of PCNA is not evolutionarily conserved.12 This underscores the significance of our findings.

Figure 1
DNA ligase I is required for S phase progression. Asynchronous cultures of ABy010 (GAL-UBR1 CDC9) and ABy008 (GAL-UBR1 cdc9-td) were grown at 28°C and arrested in G1 with α-factor. After 2 hours, Ubr1 expression was induced with 2% galactose ...
Figure 2
PCNA is sumoylated in cdc9 mutants. Wild-type (CDC9) and cdc9 mutants (cdc9-1 and cdc9-2) expressing PCNA-3HA were grown asynchronously at 25°C and shifted to 35°C for 3 hours. Whole-cell extracts were immunoprecipitated with anti-HA conjugated ...

Consistent with the observation that a DNA ligase I deficiency triggers ubiquitin conjugation at a non-canonical lysine residue of PCNA in budding yeast, we have also uncovered genetic requirements for this process that clearly distinguish it from the classical DNA damage tolerance (DDT) pathways. For example, whereas DDT is dependent on Rad6 and Rad18, both proteins are dispensable for PCNA ubiquitination in cdc9 mutants. This makes sense in as far as Rad6 and Rad18 mediate predominantly translesion synthesis,22 which would help little in facilitating the repair of nicks. Moreover, the poly-ubiquitin chains observed in cdc9 mutants are linked through lysine 29 and not lysine 63 as in PRR.18 In the light of this result, it is not surprising that Ubc13, which together with Mms2 catalyzes lysine 63 linked ubiquitin chains,7173 did not appear to play a role in this pathway.12 What was puzzling, however, was the genetic requirement for MMS2 and UBC4. The human homolog of Ubc4, UbcH5A, synthesizes lysine 29 linked ubiquitin chains in vitro.74 Although Ubc13 has been reported to function independently of Mms2,75 no other studies have demonstrated a genetic function for Mms2 that is separable from Ubc13. How Mms2 fits into the PCNA ubiquitination pathway is not at all clear and will require additional genetic validation. Furthermore, biochemical studies are currently underway to dissect whether Mms2, Ubc4 and Rad5 cooperate in one physical complex—possibly together with other proteins—or not. At this point, we have no evidence to suggest a direct interaction between Mms2 and Ubc4. Moreover, we would like to emphasize that our data does not dispute nor contradict any of the established rules for the DDT and PRR pathways.76 Rather, we interpret them to mean that both the repertoires of damaged DNA structures that cause PCNA ubiquitination as well as the pathways catalyzing these reactions are likely larger and more complex than anticipated. This is also underscored by recent observations that described the Rad6-independent ubiquitination of PCNA in response to chronic HU and MMS treatment at lysine 164.77 Although we are still missing many pieces of the puzzle, it appears that different types of DNA damage may trigger different PCNA ubiquitination pathways that result in distinct attachment sites and/or differently linked ubiquitin chains (i.e., a “DNA damage code”; Fig. 3).12

Figure 3
Damage-dependent PCNA ubiquitination in budding yeast. DNA synthesis occurs in a semi-discontinuous manner. Nascent DNA on the leading strand is synthesized by pol ε, whereas pol δ is required to synthesize Okazaki fragments (short arrows) ...

Future Challenges

Taken together, our results suggest that lagging strand synthesis is actively monitored and that persistent nicks in newly replicated DNA (and maybe also those that arise during abortive repair or result from oxidative damage) can indeed be detected during S phase. Whether earlier steps in Okazaki fragment processing are surveyed in a similar manner remains obscure. Although we tested rad27 and dna2 mutants and neither displayed PCNA ubiquitination under non-permissive conditions,12 it is highly likely that the respective enzymes substitute for one another in these particular mutants. Therefore, the lack of PCNA ubiquitination does not necessarily exclude the possibility that other OFP intermediates are recognized by the cell and trigger modification(s) of the PCNA clamp. Indeed, pol32 mutants cause lagging strand defects, which result in ss gaps.23 Although it is not clear that these gaps are generated during OFP (e.g., they might occur during actual synthesis), they cause PCNA ubiquitination. The most burning question for us concerns the biological function of ubiquitinated PCNA in cdc9 mutants. What is the connection between the modified clamp, the slow replication dynamics and Rad53 activation? Replication fork slowdown would certainly aid in extending the time frame of an individual ligation reaction. In the same vein, modified PCNA may help to retain the enzyme on site until Okazaki fragments have been successfully joined and might counteract abortive ligation reactions due to the limited amounts of DNA ligase I present in the cell. The exciting new technical developments in producing ubiquitinated PCNA in vitro78,79 certainly provide invaluable tools toward finding answers to these questions.

Acknowledgements

We thank Dr. Xiaolan Zhao for the anti-SUMO antibody and Dr. Eric A. Hendrickson for reading the manuscript. We acknowledge the assistance of the Flow Cytometry Core Facility at the University of Minnesota. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081). This work was supported by NIH grant GM074917 to A.K.B., who is a Scholar of the Leukemia and Lymphoma Society.

Abbreviations

PCNA
proliferating cell nuclear antigen
OF
Okazaki fragment
UV
ultraviolet
NER
nucleotide excision repair
MMS
methyl methane sulfonate
RPA
replication protein A
OFP
Okazaki fragment processing
PIP
PCNA interacting protein
DSBs
double strand breaks
DDT
DNA damage tolerance
PRR
post-replicative repair
SSBs
single strand breaks
pol
polymerase
ss
single strand
SUMO
small ubiquitin-like modifier

Footnotes

References

1. Hubscher U, Seo YS. Replication of the lagging strand: a concert of at least 23 polypeptides. Mol Cells. 2001;12:149–157. [PubMed]
2. Barnes DE, Tomkinson AE, Lehmann AR, Webster AD, Lindahl T. Mutations in the DNA ligase I gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA-damaging agents. Cell. 1992;69:495–503. [PubMed]
3. Webster AD, Barnes DE, Arlett CF, Lehmann AR, Lindahl T. Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. Lancet. 1992;339:1508–1509. [PubMed]
4. Prigent C, Satoh MS, Daly G, Barnes DE, Lindahl T. Aberrant DNA repair and DNA replication due to an inherited enzymatic defect in human DNA ligase I. Mol Cell Biol. 1994;14:310–317. [PMC free article] [PubMed]
5. Mackenney VJ, Barnes DE, Lindahl T. Specific function of DNA ligase I in simian virus 40 DNA replication by human cell-free extracts is mediated by the amino-terminal non-catalytic domain. J Biol Chem. 1997;272:11550–11556. [PubMed]
6. Ellenberger T, Tomkinson AE. Eukaryotic DNA ligases: Structural and functional insights. Annu Rev Biochem. 2008;77:313–338. [PMC free article] [PubMed]
7. Harrison C, Ketchen AM, Redhead NJ, O'Sullivan MJ, Melton DW. Replication failure, genome instability and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene. Cancer Res. 2002;62:4065–4074. [PubMed]
8. Bentley DJ, Harrison C, Ketchen AM, Redhead NJ, Samuel K, Waterfall M, et al. DNA ligase I null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability. J Cell Sci. 2002;115:1551–1561. [PubMed]
9. Frank G, Qiu J, Somsouk M, Weng Y, Somsouk L, Nolan JP, et al. Partial functional deficiency of E160D flap endonuclease-1 mutant in vitro and in vivo is due to defective cleavage of DNA substrates. J Biol Chem. 1998;273:33064–33072. [PubMed]
10. Zheng L, Dai H, Zhou M, Li M, Singh P, Qiu J, et al. Fen1 mutations result in autoimmunity, chronic inflammation and cancers. Nat Med. 2007;13:812–819. [PubMed]
11. Larsen E, Kleppa L, Meza TJ, Meza-Zepeda LA, Rada C, Castellanos CG, et al. Early-onset lymphoma and extensive embryonic apoptosis in two domain-specific Fen1 mice mutants. Cancer Res. 2008;68:4571–4579. [PubMed]
12. Das-Bradoo S, Nguyen HD, Wood JL, Ricke RM, Haworth JC, Bielinsky AK. Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107. Nat Cell Biol. 2010;12:74–79. [PMC free article] [PubMed]
13. Setlow RB, Swenson PA, Carrier WL. Thymine dimers and inhibition of DNA synthesis by ultraviolet irradiation of cells. Science. 1963;142:1464–1466. [PubMed]
14. Lee KY, Myung K. PCNA modifications for regulation of post-replication repair pathways. Mol Cells. 2008;26:5–11. [PubMed]
15. Bergink S, Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature. 2009;458:461–467. [PubMed]
16. Ulrich HD. Regulating post-translational modifications of the eukaryotic replication clamp PCNA. DNA Repair (Amst) 2009;8:461–469. [PubMed]
17. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell. 2007;129:665–679. [PubMed]
18. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 2002;419:135–141. [PubMed]
19. Stelter P, Ulrich HD. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature. 2003;425:188–191. [PubMed]
20. Frampton J, Irmisch A, Green CM, Neiss A, Trickey M, Ulrich HD, et al. Postreplication repair and PCNA modification in Schizosaccharomyces pombe. Mol Biol Cell. 2006;17:2976–2985. [PMC free article] [PubMed]
21. Kannouche PL, Wing J, Lehmann AR. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol Cell. 2004;14:491–500. [PubMed]
22. Daigaku Y, Davies AA, Ulrich HD. Ubiquitin-dependent DNA damage bypass is separable from genome replication. Nature. 2010;465:951–955. [PMC free article] [PubMed]
23. Karras GI, Jentsch S. The RAD6 DNA damage tolerance pathway operates uncoupled from the replication fork and is functional beyond S phase. Cell. 2010;141:255–267. [PubMed]
24. Rupp WD, Howard-Flanders P. Discontinuities in the DNA synthesized in an excision-defective strain of Escherichia coli following ultraviolet irradiation. J Mol Biol. 1968;31:291–304. [PubMed]
25. Lehmann AR. Postreplication repair of DNA in ultraviolet-irradiated mammalian cells. J Mol Biol. 1972;66:319–337. [PubMed]
26. Bridges B. Error-prone DNA repair and translesion synthesis: focus on the replication fork. DNA Repair (Amst) 2005;4:618–619. [PubMed]
27. Tercero JA, Diffley JF. Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint. Nature. 2001;412:553–557. [PubMed]
28. Stokes MP, Michael WM. DNA damage-induced replication arrest in Xenopus egg extracts. J Cell Biol. 2003;163:245–255. [PMC free article] [PubMed]
29. Niimi A, Brown S, Sabbioneda S, Kannouche PL, Scott A, Yasui A, et al. Regulation of proliferating cell nuclear antigen ubiquitination in mammalian cells. Proc Natl Acad Sci USA. 2008;105:16125–16130. [PubMed]
30. Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 2003;300:1542–1548. [PubMed]
31. Davies AA, Huttner D, Daigaku Y, Chen S, Ulrich HD. Activation of ubiquitin-dependent DNA damage bypass is mediated by replication protein A. Mol Cell. 2008;29:625–636. [PMC free article] [PubMed]
32. Yang XH, Zou L. Dual functions of DNA replication forks in checkpoint signaling and PCNA ubiquitination. Cell Cycle. 2009;8:191–194. [PMC free article] [PubMed]
33. Tomkinson AE, Vijayakumar S, Pascal JM, Ellenberger T. DNA ligases: structure, reaction mechanism and function. Chem Rev. 2006;106:687–699. [PubMed]
34. Rossi ML, Bambara RA. Reconstituted Okazaki fragment processing indicates two pathways of primer removal. J Biol Chem. 2006;281:26051–26061. [PubMed]
35. Garg P, Stith CM, Sabouri N, Johansson E, Burgers PM. Idling by DNA polymerase delta maintains a ligatable nick during lagging-strand DNA replication. Genes Dev. 2004;18:2764–2773. [PubMed]
36. Jin YH, Garg P, Stith CM, Al-Refai H, Sterling JF, Murray LJ, et al. The multiple biological roles of the 3′—>5′ exonuclease of Saccharomyces cerevisiae DNA polymerase delta require switching between the polymerase and exonuclease domains. Mol Cell Biol. 2005;25:461–471. [PMC free article] [PubMed]
37. Stith CM, Sterling J, Resnick MA, Gordenin DA, Burgers PM. Flexibility of eukaryotic Okazaki fragment maturation through regulated strand displacement synthesis. J Biol Chem. 2008;283:34129–34140. [PubMed]
38. Lee KH, Kim DW, Bae SH, Kim JA, Ryu GH, Kwon YN, et al. The endonuclease activity of the yeast Dna2 enzyme is essential in vivo. Nucleic Acids Res. 2000;28:2873–2881. [PMC free article] [PubMed]
39. Budd ME, Choe W, Campbell JL. The nuclease activity of the yeast DNA2 protein, which is related to the RecB-like nucleases, is essential in vivo. J Biol Chem. 2000;275:16518–16529. [PubMed]
40. Ayyagari R, Gomes XV, Gordenin DA, Burgers PM. Okazaki fragment maturation in yeast. I. Distribution of functions between FEN1 and DNA2. J Biol Chem. 2003;278:1618–1625. [PubMed]
41. Rossi ML, Pike JE, Wang W, Burgers PM, Campbell JL, Bambara RA. Pif1 helicase directs eukaryotic Okazaki fragments toward the two-nuclease cleavage pathway for primer removal. J Biol Chem. 2008;283:27483–27493. [PubMed]
42. Karanja KK, Livingston DM. C-terminal flap endonuclease (rad27) mutations: lethal interactions with a DNA ligase I mutation (cdc9-p) and suppression by proliferating cell nuclear antigen (POL30) in Saccharomyces cerevisiae. Genetics. 2009;183:63–78. [PubMed]
43. Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003;116:3051–3060. [PubMed]
44. Sakurai S, Kitano K, Yamaguchi H, Hamada K, Okada K, Fukuda K, et al. Structural basis for recruitment of human flap endonuclease 1 to PCNA. EMBO J. 2005;24:683–693. [PubMed]
45. Vijayakumar S, Chapados BR, Schmidt KH, Kolodner RD, Tainer JA, Tomkinson AE. The C-terminal domain of yeast PCNA is required for physical and functional interactions with cdc9 DNA ligase. Nucleic Acids Res. 2007;35:1624–1637. [PMC free article] [PubMed]
46. Bielinsky AK, Gerbi SA. Chromosomal ARS1 has a single leading strand start site. Mol Cell. 1999;3:477–486. [PubMed]
47. Johnston LH, Nasmyth KA. Saccharomyces cerevisiae cell cycle mutant cdc9 is defective in DNA ligase. Nature. 1978;274:891–893. [PubMed]
48. Johnston LH. The cdc9 ligase joins completed replicons in baker's yeast. Mol Gen Genet. 1983;190:315–317. [PubMed]
49. Culotti J, Hartwell LH. Genetic control of the cell division cycle in yeast. 3. Seven genes controlling nuclear division. Exp Cell Res. 1971;67:389–401. [PubMed]
50. Weinert TA, Kiser GL, Hartwell LH. Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair. Genes Dev. 1994;8:652–665. [PubMed]
51. Montelone BA, Prakash S, Prakash L. Spontaneous mitotic recombination in mms8-1, an allele of the CDC9 gene of Saccharomyces cerevisiae. J Bacteriol. 1981;147:517–525. [PMC free article] [PubMed]
52. Shibahara K, Stillman B. Replication-dependent marking of DNA by PCNA facilitates CAF-1-coupled inheritance of chromatin. Cell. 1999;96:575–585. [PubMed]
53. Branzei D, Foiani M. Interplay of replication checkpoints and repair proteins at stalled replication forks. DNA Repair (Amst) 2007;6:994–1003. [PubMed]
54. Sweeney FD, Yang F, Chi A, Shabanowitz J, Hunt DF, Durocher D. Saccharomyces cerevisiae Rad9 acts as a Mec1 adaptor to allow Rad53 activation. Curr Biol. 2005;15:1364–1375. [PubMed]
55. Osborn AJ, Elledge SJ. Mrc1 is a replication fork component whose phosphorylation in response to DNA replication stress activates Rad53. Genes Dev. 2003;17:1755–1767. [PubMed]
56. Naylor ML, Li JM, Osborn AJ, Elledge SJ. Mrc1 phosphorylation in response to DNA replication stress is required for Mec1 accumulation at the stalled fork. Proc Natl Acad Sci USA. 2009;106:12765–12770. [PubMed]
57. Kumagai A, Dunphy WG. Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts. Mol Cell. 2000;6:839–849. [PubMed]
58. Alcasabas AA, Osborn AJ, Bachant J, Hu F, Werler PJ, Bousset K, et al. Mrc1 transduces signals of DNA replication stress to activate Rad53. Nat Cell Biol. 2001;3:958–965. [PubMed]
59. Tanaka K, Russell P. Mrc1 channels the DNA replication arrest signal to checkpoint kinase Cds1. Nat Cell Biol. 2001;3:966–972. [PubMed]
60. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M. Rad18 guides pol eta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 2004;23:3886–3896. [PubMed]
61. Zhuang Z, Johnson RE, Haracska L, Prakash L, Prakash S, Benkovic SJ. Regulation of polymerase exchange between Poleta and Poldelta by monoubiquitination of PCNA and the movement of DNA polymerase holoenzyme. Proc Natl Acad Sci USA. 2008;105:5361–5366. [PubMed]
62. Terai K, Abbas T, Jazaeri AA, Dutta A. CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis. Mol Cell. 2010;37:143–149. [PMC free article] [PubMed]
63. Torres-Ramos CA, Prakash S, Prakash L. Requirement of RAD5 and MMS2 for postreplication repair of UV-damaged DNA in Saccharomyces cerevisiae. Mol Cell Biol. 2002;22:2419–2426. [PMC free article] [PubMed]
64. Blastyak A, Pinter L, Unk I, Prakash L, Prakash S, Haracska L. Yeast Rad5 protein required for postreplication repair has a DNA helicase activity specific for replication fork regression. Mol Cell. 2007;28:167–175. [PMC free article] [PubMed]
65. Branzei D, Vanoli F, Foiani M. SUMOylation regulates Rad18-mediated template switch. Nature. 2008;456:915–920. [PubMed]
66. Minca EC, Kowalski D. Multiple Rad5 activities mediate sister chromatid recombination to bypass DNA damage at stalled replication forks. Mol Cell. 2010;38:649–661. [PMC free article] [PubMed]
67. Windecker H, Ulrich HD. Architecture and assembly of poly-SUMO chains on PCNA in Saccharomyces cerevisiae. J Mol Biol. 2008;376:221–231. [PubMed]
68. Haracska L, Torres-Ramos CA, Johnson RE, Prakash S, Prakash L. Opposing effects of ubiquitin conjugation and SUMO modification of PCNA on replicational bypass of DNA lesions in Saccharomyces cerevisiae. Mol Cell Biol. 2004;24:4267–4274. [PMC free article] [PubMed]
69. Papouli E, Chen S, Davies AA, Huttner D, Krejci L, Sung P, et al. Crosstalk between SUMO and ubiquitin on PCNA is mediated by recruitment of the helicase Srs2p. Mol Cell. 2005;19:123–133. [PubMed]
70. Branzei D, Sollier J, Liberi G, Zhao X, Maeda D, Seki M, et al. Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks. Cell. 2006;127:509–522. [PubMed]
71. Eddins MJ, Carlile CM, Gomez KM, Pickart CM, Wolberger C. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation. Nat Struct Mol Biol. 2006;13:915–920. [PubMed]
72. VanDemark AP, Hofmann RM, Tsui C, Pickart CM, Wolberger C. Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer. Cell. 2001;105:711–720. [PubMed]
73. Hofmann RM, Pickart CM. Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell. 1999;96:645–653. [PubMed]
74. Mastrandrea LD, You J, Niles EG, Pickart CM. E2/E3-mediated assembly of lysine 29-linked polyubiquitin chains. J Biol Chem. 1999;274:27299–27306. [PubMed]
75. Stewart GS, Panier S, Townsend K, Al-Hakim AK, Kolas NK, Miller ES, et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell. 2009;136:420–434. [PubMed]
76. Ulrich HD, Walden H. Ubiquitin signalling in DNA replication and repair. Nat Rev Mol Cell Biol. 2010;11:479–489. [PubMed]
77. Kats ES, Enserink JM, Martinez S, Kolodner RD. The Saccharomyces cerevisiae Rad6 postreplication repair and Siz1/Srs2 homologous recombination-inhibiting pathways process DNA damage that arises in asf1 mutants. Mol Cell Biol. 2009;29:5226–5237. [PMC free article] [PubMed]
78. Freudenthal BD, Gakhar L, Ramaswamy S, Washington MT. Structure of monoubiquitinated PCNA and implications for translesion synthesis and DNA polymerase exchange. Nat Struct Mol Biol. 2010;17:479–484. [PMC free article] [PubMed]
79. Chen J, Ai Y, Wang J, Haracska L, Zhuang Z. Chemically ubiquitylated PCNA as a probe for eukaryotic translesion DNA synthesis. Nat Chem Biol. 2010;6:270–272. [PubMed]
80. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–1612. [PubMed]

Articles from Cell Cycle are provided here courtesy of Landes Bioscience